FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109478087> ?p ?o ?g. }

• W2109478087 endingPage "1469" @default.
• W2109478087 startingPage "1462" @default.
• W2109478087 abstract "OBJECTIVE Long-chain n-3 polyunsaturated fatty acid (n-3 PUFA) supplements may have renoprotective effects in patients with diabetes, but previous trials have been inconsistent. We performed a randomized controlled trial of n-3 PUFA supplementation on urine albumin excretion and markers of kidney injury in adults with type 2 diabetes. RESEARCH DESIGN AND METHODS We conducted a randomized, placebo-controlled, two-period crossover trial to test the effects of 4 g/day of n-3 PUFA supplementation on markers of glomerular filtration and kidney injury in adults with adult-onset diabetes and greater than or equal to trace amounts of proteinuria. Each period lasted 6 weeks and was separated by a 2-week washout. The main outcome was urine albumin excretion and, secondarily, markers of kidney injury (kidney injury molecule-1, N-acetyl β-d-glucosaminidase [NAG], neutrophil gelatinase-associated lipocalin [NGAL], and liver fatty acid–binding protein [LFABP]), serum markers of kidney function (cystatin C, β2-microglobulin, and creatinine), and estimated glomerular filtration rate (eGFR). RESULTS Of the 31 participants, 29 finished both periods. A total of 55% were male, and 61% were African American; mean age was 67 years. At baseline, mean BMI was 31.6 kg/m2, median eGFR was 76.9 mL/min/1.73 m2, and median 24-h urine albumin excretion was 161 mg/day. Compared with placebo, n-3 PUFA had nonsignificant effects on urine albumin excretion (−7.2%; 95% CI −20.6 to 8.5; P = 0.35) and significant effects on urine NGAL excretion (−16% [−29.1 to −0.5%]; P = 0.04). There was no effect on serum markers of kidney function or eGFR. In subgroup analyses, there were significant decreases in 24-h urinary excretion of albumin, NGAL, LFABP, and NAG among participants taking medications that block the renin-angiotensin-aldosterone system (RAAS). CONCLUSIONS These results suggest a potential effect of n-3 PUFA supplementation on markers of kidney injury in patients with diabetes and early evidence of kidney disease. In the context of prior studies, these results provide a strong rationale for long-term trials of n-3 PUFA on chronic kidney disease progression." @default.
• W2109478087 created "2016-06-24" @default.
• W2109478087 creator A5039267010 @default.
• W2109478087 creator A5044576014 @default.
• W2109478087 creator A5045050293 @default.
• W2109478087 creator A5048680434 @default.
• W2109478087 creator A5053852808 @default.
• W2109478087 creator A5064188100 @default.
• W2109478087 creator A5064192167 @default.
• W2109478087 creator A5067986631 @default.
• W2109478087 creator A5089812930 @default.
• W2109478087 date "2013-05-15" @default.
• W2109478087 modified "2023-09-25" @default.
• W2109478087 title "The Effects of n-3 Long-Chain Polyunsaturated Fatty Acid Supplementation on Biomarkers of Kidney Injury in Adults With Diabetes" @default.
• W2109478087 cites W1560062315 @default.
• W2109478087 cites W1965311688 @default.
• W2109478087 cites W1985289985 @default.
• W2109478087 cites W1992286466 @default.
• W2109478087 cites W1995321930 @default.
• W2109478087 cites W1995888336 @default.
• W2109478087 cites W2020495368 @default.
• W2109478087 cites W2030957590 @default.
• W2109478087 cites W2034128105 @default.
• W2109478087 cites W2035033082 @default.
• W2109478087 cites W2052211531 @default.
• W2109478087 cites W2058616836 @default.
• W2109478087 cites W2073182011 @default.
• W2109478087 cites W2073742622 @default.
• W2109478087 cites W2082262509 @default.
• W2109478087 cites W2083847295 @default.
• W2109478087 cites W2087949182 @default.
• W2109478087 cites W2091775190 @default.
• W2109478087 cites W2093949592 @default.
• W2109478087 cites W2105206504 @default.
• W2109478087 cites W2109181554 @default.
• W2109478087 cites W2111416360 @default.
• W2109478087 cites W2111876001 @default.
• W2109478087 cites W2116404316 @default.
• W2109478087 cites W2116474837 @default.
• W2109478087 cites W2118270134 @default.
• W2109478087 cites W2142347023 @default.
• W2109478087 cites W2170666697 @default.
• W2109478087 cites W2192223169 @default.
• W2109478087 cites W2317235285 @default.
• W2109478087 cites W4231980339 @default.
• W2109478087 cites W4300644930 @default.
• W2109478087 doi "https://doi.org/10.2337/dc12-1940" @default.
• W2109478087 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3661851" @default.
• W2109478087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23275364" @default.
• W2109478087 hasPublicationYear "2013" @default.
• W2109478087 type Work @default.
• W2109478087 sameAs 2109478087 @default.
• W2109478087 citedByCount "44" @default.
• W2109478087 countsByYear W21094780872013 @default.
• W2109478087 countsByYear W21094780872014 @default.
• W2109478087 countsByYear W21094780872015 @default.
• W2109478087 countsByYear W21094780872016 @default.
• W2109478087 countsByYear W21094780872017 @default.
• W2109478087 countsByYear W21094780872018 @default.
• W2109478087 countsByYear W21094780872019 @default.
• W2109478087 countsByYear W21094780872020 @default.
• W2109478087 countsByYear W21094780872021 @default.
• W2109478087 countsByYear W21094780872022 @default.
• W2109478087 countsByYear W21094780872023 @default.
• W2109478087 crossrefType "journal-article" @default.
• W2109478087 hasAuthorship W2109478087A5039267010 @default.
• W2109478087 hasAuthorship W2109478087A5044576014 @default.
• W2109478087 hasAuthorship W2109478087A5045050293 @default.
• W2109478087 hasAuthorship W2109478087A5048680434 @default.
• W2109478087 hasAuthorship W2109478087A5053852808 @default.
• W2109478087 hasAuthorship W2109478087A5064188100 @default.
• W2109478087 hasAuthorship W2109478087A5064192167 @default.
• W2109478087 hasAuthorship W2109478087A5067986631 @default.
• W2109478087 hasAuthorship W2109478087A5089812930 @default.
• W2109478087 hasBestOaLocation W21094780871 @default.
• W2109478087 hasConcept C10146269 @default.
• W2109478087 hasConcept C126322002 @default.
• W2109478087 hasConcept C134018914 @default.
• W2109478087 hasConcept C159641895 @default.
• W2109478087 hasConcept C2776125364 @default.
• W2109478087 hasConcept C2776174234 @default.
• W2109478087 hasConcept C2779561371 @default.
• W2109478087 hasConcept C2780026642 @default.
• W2109478087 hasConcept C2780091579 @default.
• W2109478087 hasConcept C2780306776 @default.
• W2109478087 hasConcept C2780472472 @default.
• W2109478087 hasConcept C555293320 @default.
• W2109478087 hasConcept C71924100 @default.
• W2109478087 hasConceptScore W2109478087C10146269 @default.
• W2109478087 hasConceptScore W2109478087C126322002 @default.
• W2109478087 hasConceptScore W2109478087C134018914 @default.
• W2109478087 hasConceptScore W2109478087C159641895 @default.
• W2109478087 hasConceptScore W2109478087C2776125364 @default.
• W2109478087 hasConceptScore W2109478087C2776174234 @default.
• W2109478087 hasConceptScore W2109478087C2779561371 @default.
• W2109478087 hasConceptScore W2109478087C2780026642 @default.
• W2109478087 hasConceptScore W2109478087C2780091579 @default.
• W2109478087 hasConceptScore W2109478087C2780306776 @default.

• next